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Reactivation of latent murine cytomegalovirus from kidney.
Cytomegalovirus (CMV) is presumed to cause latent infection, but the
sites of infection are incompletely known. We propose that latent
murine cytomegalovirus is present in kidney and may be reactivated by
explantation. Immunosuppressive agents and allogeneic stimuli may
enhance this process. Balb/c mice were infected 11 to 14 months
previously with l0 pfu of Smith strain murine cytomegalovirus intra-
peritoneally. Kidneys from 15 infected and nine uninfected mice were
washed, minced into 1 to 2 mm2 explants and placed into separate tissue
culture wells containing a mouse embryo fibroblast monolayer. Ex-
plants were untreated or treated with azathioprine, cyclophosphamide,
anti-thymocyte serum, or allogeneic lymphocytes. Daily observations
for CPE and passage of supernatant to fresh mouse embryo fibroblast
were done. Standard cultures of blood, kidney, and salivary gland were
negative. However, virus was isolated from the explants of 8/15
animals, with a reactivation time of 30 to 70 days. No significant
difference in reactivation time was noted between treated or untreated
explants. Restriction enzyme analysis of viral DNA confirmed identity
with the original strain. These data show that latent murine
cytomegalovirus is present in murine kidney tissue and may be reacti-
vated by explantation.
Reactivation d'une infection latente a cytomegalovirus a partir du rein
de souris. Le cytomegalovirus (CMV) est considéré comme susceptible
de provoquer une infection latente, mais les sites de cette infection sont
incompletement connus. Nous proposons qu'une infection latente par
Ic CMV murin est prdsente dans le rein et peut être réactivée par Ia mise
en culture. Les agents immunosuppresseurs et les stimuli allogéniques
peuvent augmenter ce processus. Des souris Balb/c ont été infectées
par voie intrapéritonéale par i0 ufp d'une souche de cytomégalovirus
murin Smith, ii a 14 mois avant l'expérimentation. Les reins de 15
souris infectdes et de 9 souris non infectées ont été lavés, hachés en
explants de 1 a 2 mm2 et ddposés dans des puits de culture tissulaire
séparés contenant une couche monocellulaire de fibroblastes
d'embryons de souris. Les explants ont été traités ou non par
l'azathioprine, Ia cyclophosphamide, le serum anti-thymocyte, ou des
lymphocytes allogeniques. Une observation quotidienne de l'effet
cytopathogéne et du passage du surnageant sur des fibroblastes
d'embryons de souris frais a été pratiquée. Les cultures standard du
sang, du rein, des glandes salivaires ont éte negatives. A l'opposC, Ic
virus a été isold des explants de 8 animaux sur 15, avec un temps de
reactivation de 30 fl 70 jours. Aucune difference dans le délai de
reactivation n'a été notCe entre les explants traités ou non traités. Une
analyse du DNA viral par enzyme de restriction a confirmé l'identité
avec la souche originelle. Ces donnCes montrent qu'une infection
latente par le CMV murin est prCsente dans Ic tissu renal murin et peut
être rdactivée par Ia mise en culture.
Human cytomegalovirus (HCMV) causes widespread infec-
tion in both normal and immunocompromised human hosts [1].
Unlike most viral infections wherein the offending agent is
eventually eliminated, HCMV persists in a dormant or latent
form. In contrast to other Herpes viruses, the sites of latent
HCMV are less certain. Through epidemiological and circum-
stantial evidence, the kidney has been implicated as one possi-
ble site [2—4]. Direct evidence is limited [5].
In our study, a murine kidney explantation model was used to
further define the kidney as a reservoir of latent cytomegalo-
virus. The results demonstrate that murine cytomegalovirus
(MCMV) is present in the kidney tissue of latently infected mice
and can be reactivated by explantation.
Methods
Animals
Adult male and female infection-free outbred CD' and inbred
Balb/c (H-2d) mice were obtained from the National Cancer
Institute. The animals were fed standard rat chow and water ad
libitum and were maintained in segregated cages until used.
Virus
Smith strain MCMV (obtained from Dr. David Lang) was
maintained by passage through uninfected Balb/c mice and
stored at —170°C in liquid nitrogen.
Establishment of latency
Weanling Balb/c mice were given io pfu of Smith strain
MCMV intraperitoneally in 0.5 ml tissue culture media and
maintained in segregated environments. Serial tissue cultures of
salivary gland, kidney, blood, spleen, and lymph nodes con-
firmed the lack of detectable virus in any organ 3 to 4 months
after infection. All animals infected more than 6 months previ-
ously were therefore assumed to be latently infected. In our
experiments, only mice infected 11 to 14 months previously
were used.
Tissue culture
Using CD' embryonic fibroblast cells, tissue cultures were
prepared by methods described elsewhere [6]. Virus was iden-
tified by the appearance of cytopathic effects (CPE), typical of
MCMV.
Explant technique
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Kidneys from infected and uninlected Balb/c mice were
removed, perfused with 5 ml of a phosphate buffered salt
solution, sectioned into 1 to 2 mm2 slices and washed free of
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contaminating blood. Two slices were placed into each well of
24-well tissue culture plate (Costar-l6 mm wells, Cambridge,
Massachusetts, USA) and allowed to attach for 5 to 10 mm.
They were then overlaid with a suspension of CD' mouse
embryo fibroblast (MEF) in minimal essential media (MEM)
with 5% fetal calf serum (FCS). Specimens were either un-
treated or treated with azathioprine (Imuran; Burroughs-
Welicome, Research Triangle Park, North Carolina, USA) 0.1
sg!ml, cyclophosphamide (Cytoxan; Mead Johnson Laborato-
ries, Evansville, Indiana, USA) 0.1 g/m1, antithymocyte sera
(ATS; M. A. Bioproducts, Walkersville, Maryland, USA) 0.1
ml or allogeneic lymphocytes 8 x io cells/ml. The plates were
incubated in a 5% CO2 atmosphere and examined every 1 to 2
days for CPE. Medium from each well was cultured on fresh
MEF at weekly intervals for 80 days and the medium was
completely changed after each sampling. No additional im-
munosuppressive agents were added after 7 days. The medium
from any positive well was cultured a second time to confirm
the presence of infectious virus.
DNA restriction endonuclease analysis
Restriction enzyme analysis of purified viral DNA was per-
formed on explant isolates by the method of Huang [7]. In
summary, samples of the reactivated virus and the original
Smith strain MCMV were grown on fresh MEF and labeled
with 32P at the first sign of CPE. The cell layer was extracted
with a 1% SDS, 5 to 10 mrvi EDTA pH 8, 20 to 50 mM Tris
solution after 100% CPE was observed. An overnight pronase
digestion was carried out at 37°C and the samples extracted
twice with distilled phenol. The DNA was precipitated with
cold 95% ethanol, allowed to stand at —20°C overnight, and
resuspended in 5 ml of a 20 mrvi Tris-HC1, 5 mM EDTA pH 8
solution. Viral DNA was purified by cesium chloride density
centrifugation and dialyzed against a Tris buffered saline solu-
tion (TBS). The purified DNA was re-precipitated with cold
95% ethanol, dissolved in TBS, and digested with restriction
enzymes Eco R. 1, and Bam H (Bethesda Research Laborato-
ries, Baltimore, Maryland, USA). The digested specimens were
then subjected to agarose gel electrophoresis. Autoradiography
was performed to define the DNA digest patterns.
Results
Uninfected animals had no detectable virus at any interval by
both standard tissue culture and explantation. In acutely in-
fected mice, MCMV was detectable in the salivary gland by
tissue culture up to 98 days after infection (Fig. 1). Kidney,
blood, spleen, and lymph nodes were positive for much shorter
periods. Although the animals infected 11 to 14 months previ-
ously (latent infection) demonstrated no virus in blood, kidney,
or spleen by standard methods, MCMV was identified in the
media of kidney explants from eight out of 15 different latently
infected animals (Table 1). Of all kidney specimens, 30% were
noted to produce virus. MCMV was confirmed by second
passage in all instances.
Immunosuppressive agents and allogeneic stimuli appeared
to have no significant influence on reactivation. This was
reflected in the similar number of positive explants and latently
infected animals identified for each treatment group (Table 2).
The time required for virus to appear in media ranged from 30
Days in
Standard cultures
Cumulative
animals withSalivary
culture Blood Kidney gland positive explants
25 0/15 0/15 0/15 0/15
30 0/15 0/15 0/15 2/15
36 0/15 0/15 0/15 3/15
45 0/15 0/15 0/15 5/15
50 0/15 0/15 0/15 6/15
70 — — — 8/15
to 70 days, but the differences in mean reactivation times among
the various groups were not statistically significant.
DNA restriction enzyme analysis of the viral isolates verified
them to be the initial infecting Smith strain MCMV. Figure 2
illustrates the DNA digest patterns of two isolates as compared
to those of the original virus.
Table 3 shows the results of explantation of the spleen and
kidney from the same latently infected mice. Spleen explants
were more commonly positive (55/100) and at shorter intervals
after explantation than were the kidney explants (40/100). No
differences were detected in the reactivation rate in the different
immunosuppressive regimens.
Discussion
Cytomegalovirus studies on renal transplant recipients have
yielded evidence suggesting that latent human cytomegalovirus
(HCMV) resides in the kidney. Work by Betts et al shows that
approximately 75% of CMV seronegative recipients of renal
allografts from seropositive donors will shed virus post trans-
plantation. Seronegative recipients of kidneys from seronega-
tive donors almost never shed virus [2]. Similar results were
obtained in other studies by May et al and Pass et a! [3, 41.
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Fig. 1. Organ viral titers up to 1 year after acute infection. Each point
on the graph represents the mean of three animals. No animals beyond
100 days were positive on culture from any tested organ or body fluid.
Symbols are: •, salivary gland; , spleen; A, lymph nodes; 0, kidney.
Table 1. Explant and standard culture results in latently infected
micea
56 84 112 280 336
a Results expressed as number of latently infected animals posi-
tive/total number of animals.
.4
a
nI
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Table 2. Number of latently infected animals identified by each treatment and reactivation timesa
Treatment group
Total latently
infected mice
Latent mice
identified
Explants
done
Explants
positive
Reactivation
time, days (Mean)
Untreated
Cyclophosphamide
Anti-thymocyte sera
Allogeneic lymphocytes
Azathioprine
15
15
15
15
15
5
3
6
5
6
60
60
60
60
60
18
16
20
16
18
36 to 50
30 to 45
30 to 70
30 to 45
30 to 70
(40.6)
(35)
(48.0)
(37.2)
(41.2)
a No statistically significant differences were detectable between any treatment group or untreated controls by the Wilcoxon rank sum test.
Table 3. Comparison of kidney and spleen explant cultures from
latently infected animals
Treatment group
Total
latently
infected
mice
Explants
Positive/Done
Kidney Spleen
Reactivation time,
days
Kidney Spleen
Untreated 5 8/20 9/20 36 to 45 30 to 26
Cyclophosphamide 5 8/20 12/20 30 to 45 23 to 36
Anti-thymocyte
sera 5 6/20 12/20 30 to 45 13 to 45
Allogeneic
lymphocytes 5 10/20 9/20 30 to 45 19 to 45
Azathioprine 5 8/20 13/20 30 to 45 30 to 45
Fig. 2. Restriction enzyme DNA digest patterns of parental Smith strain
MCMV and the reactivated viral isolate.
These observations implied that the source of CMV was the
renal allograft itself.
Definitive confirmation of these suspicions by in vitro studies
is, for the most part, lacking. The single exception comes from
Orsi et al who isolated CMV from human kidney specimens
from eight out of 10 (80%) normal donors using standard tissue
culture and immunofluorescent techniques [5]. Murine studies
have also failed to yield verifying information concerning the
kidney and CMV latency. Wise et a! demonstrated an inability
to detect virus in kidney explants from mice beyond 28 days
post infection despite recovering MCMV for up to 5 months
from spleen explants [8]. Earlier investigations by Olding et a!
produced similar results [91. We postulate that differences in the
duration of explant follow-up, frequency of sampling, quantity
of original inoculum, and the small number of test samples may
account for the differences observed in our study.
The results in our study provide convincing evidence that the
kidney is a site of latent MCMV. We were able to isolate virus
from the kidneys of animals that were approximately 1 year
post infection and virus free by standard culture methods. The
presence of these conditions signified the reactivation of latent
infection. Recovering MCMV from only 30% of the explants
suggested that the virus or viral DNA was present in small
quantities.
In vivo murine studies have shown immunosuppressive
agents to promote reactivation of latent MCMV [10—13]. Fur-
ther, virus has been reactivated from bone marrow-derived
lymphocytes by in vitro allogeneic stimulation [141. Whether
these agents have any direct influence on reactivation of latent
virus from kidney tissue has not yet been determined. Our data
demonstrate these factors to have no in vitro effect on this
process, as indicated by the similar mean reactivation times
between untreated and treated specimens (Table 2). That
cyclophosphamide requires in vivo oxidation for its alkylating
activity may have influenced our inability to detect in vitro
reactivation however.
The reasons why explantation reactivates latent MCMV are
unknown. We postulate, however, that by removing the kidney
from its normal immunological constraints, spontaneous viral
reactivation may be allowed expression. Another theory may
involve changes in the renal cell replication cycle that result in
the production of substances crucial to viral reactivation and
replication. Support for this idea comes from studies by Dutko
which show that cellular differentiation may promote viral
reactivation [151. Lastly, the minimal cellular trauma involved
in explantation may yield a greater probability of successfully
culturing the small number of latently infected cells.
Reactivated
strain
Parental
strain
Reactivated
strain
BamH BamH EcoR1 EcoR1
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Because of the extreme difficulty in completely eliminating
blood from renal tissue, it is conceivable that residual latently
infected lymphocytes [16—18] could have served as an addi-
tional source of reactivated virus. The ability of murine fibro-
blast to also harbor latent MCMV [19] creates another possible
source. Unfortunately, present technology will not permit con-
clusive determination of the relative contributions of each cell
type. Nonetheless, the purpose of this study was not to examine
the role of the kidney's cellular constituents in viral reactiva-
tion, but to show that this organ is capable of harboring and
transmitting latent MCMV.
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